As weary travelers relax during the holiday season, SITA’s Simon Lomas says aviation leaders are increasing the use of artificial intelligence to guide our journeys
According to the settlement agreement, the proposed biosimilar to Eylea® (aflibercept) can be marketed in the U.S., if approved by the FDA, in the fourth quarter of 2026, or earlier under certai......
